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Introduction
An increased incidence of cardiovascular disease has been
found in rheumatic disorders. Juvenile idiopathic arthritis
(JIA) is the most common chronic rheumatic disease in
children. Prolonged immunological inflammatory process
leads in these patients to an early onset of atherosclerosis.
Objectives
We aimed to assess the presence of early vascular dysfunc-
tion in patients with systemic onset juvenile idiopathic
arthritis (SoJIA) and investigate the role of therapy SoJIA
in vascular health.
Methods
Eighteen patients ( 12 males, 6 females) with diagnosis of
SoJIA according to the International League of Associa-
tions for Rheumatology criteria were compared to 75 age-
and sex-matched controls. No participant was overweight,
obese, or had a history of hypertension, dyslipidemia, dia-
betes mellitus, or cardiovascular disease. Arterial stiffness
(As) was evaluated by measurement of carotid-femoral
pulse wave velocity (PWV) and augmentation index (AIx)
with Vicorder.
Results
The mean age onset of disease was 80,4±28,7 months
(range 36-122months). The mean duration of disease and
active disease was 79 ± 45 months (range 6–162 months)
and 58 ± 49 months (range 1–161 months), respectively.
Patients with SoJIA presented a higher mean PWV and
AIx than in controls [(6.16±1.45 m/s vs 5.19±0.63 m/s,
P =0.01)and (14.7 ± 8.1%vs 10.4 ± 7.35%,P =0.02)]. Eight
(44%) patients with JIA had active disease at study entry.
The highest levels of PWV and Aix were found in active
patients. Six patients had been macrophage activation
syndrome at presentation. In these patients, vascular
changes higher than other patients (6.30±0.42 m/s vs 5.17
±0.55 m/s,P =0.01, respectively). The corticosteroid ther-
apy was found associated with higher PWV, (P< 0.05),
while there was not different between vascular parameters
and used non steroid therapy (NSAIDs, MTX, or anti-
TNF agents). We also find statistically significant correla-
tion between PWV and disease duration (p = 0.003,
r = 0.45).
Conclusion
Vascular function is impaired in patients with SoJIA at a
very young age. Vascular dysfunction may be partly
attributed to the effects of disease-related characteristics
(inflammation, disease activity, and medications).
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